➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Baxter
McKinsey
Mallinckrodt
AstraZeneca

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Zydus Pharms Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and three approved drugs.

There are nineteen tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms
US Patents:0
Tradenames:174
Ingredients:173
NDAs:203

Drugs and US Patents for Zydus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc GLIPIZIDE AND METFORMIN HYDROCHLORIDE glipizide; metformin hydrochloride TABLET;ORAL 078905-002 Jan 31, 2011 AB RX No No   Start Trial   Start Trial
Zydus Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206641-006 Aug 11, 2017 AB4 RX No No   Start Trial   Start Trial
Zydus Pharms Usa AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 078226-001 Jul 9, 2007 AB RX No No   Start Trial   Start Trial
Zydus Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206534-005 Aug 8, 2017 AB3 RX No No   Start Trial   Start Trial
Zydus Pharms Usa RIBAVIRIN ribavirin CAPSULE;ORAL 077224-001 Oct 28, 2005 AB RX No No   Start Trial   Start Trial
Zydus Pharms MEMANTINE HYDROCHLORIDE memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 203293-001 Aug 3, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa Inc OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 091352-001 Nov 19, 2012 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
AstraZeneca
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.